Cargando…
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors
[Image: see text] Antigen-presenting cells (APCs) orchestrate immune responses and are therefore of interest for the targeted delivery of therapeutic vaccines. Dendritic cells (DCs) are professional APCs that excel in presentation of exogenous antigens toward CD4(+) T helper cells, as well as cytoto...
Autores principales: | Wijfjes, Zacharias, van Dalen, Floris J., Le Gall, Camille M., Verdoes, Martijn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548474/ https://www.ncbi.nlm.nih.gov/pubmed/37721387 http://dx.doi.org/10.1021/acs.molpharmaceut.3c00330 |
Ejemplares similares
-
Inhibitory prodrug mechanism for cysteine cathepsin-targeted self-controlled drug release
por: van Dalen, Floris J., et al.
Publicado: (2022) -
Dual Site-Specific Chemoenzymatic Antibody Fragment
Conjugation Using CRISPR-Based Hybridoma Engineering
por: Le Gall, Camille M., et al.
Publicado: (2021) -
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion
por: Le Gall, Camille, et al.
Publicado: (2022) -
Distinct antigen uptake receptors route to the same storage compartments for cross‐presentation in dendritic cells
por: Ho, Nataschja I., et al.
Publicado: (2021) -
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody
por: van Elsas, Marit J., et al.
Publicado: (2022)